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a b s t r a c t
The Centers for High Cost Medication (Centros de Medicação de Alto Custo, CEDMAC), 
Health Department, São Paulo were instituted by project in partnership with the Clini-
cal Hospital of the Faculty of Medicine, USP, sponsored by the Foundation for Research 
Support of the State of São Paulo (Fundação de Amparo à Pesquisa do Estado de São 
Paulo, FAPESP) aimed at the formation of a statewide network for comprehensive care of 
patients referred for use of immunobiological agents in rheumatological diseases. The 
CEDMAC of Hospital de Clínicas, Universidade Estadual de Campinas (HC-Unicamp), im-
plemented by the Division of Rheumatology, Faculty of Medical Sciences, identified the 
need for standardization of the multidisciplinary team conducts, in face of the specificity 
of care conducts, verifying the importance of describing, in manual format, their opera-
tional and technical processes. The aim of this study is to present the methodology ap-
plied to the elaboration of the CEDMAC/HC-Unicamp Manual as an institutional tool, with 
the aim of offering the best assistance and administrative quality. In the methodology 
for preparing the manuals at HC-Unicamp since 2008, the premise was to obtain a docu-
ment that is participatory, multidisciplinary, focused on work processes integrated with 
institutional rules, with objective and didactic descriptions, in a standardized format and 
with electronic dissemination. The CEDMAC/HC-Unicamp Manual was elaborated in 10 
months, with involvement of the entire multidisciplinary team, with 19 chapters on work 
processes and techniques, in addition to those concerning the organizational structu-
re and its annexes. Published in the electronic portal of HC Manuals in July 2012 as an 
e -Book (ISBN 978-85-63274-17-5), the manual has been a valuable instrument in guiding 
professionals in healthcare, teaching and research activities.
© 2014 Sociedade Brasileira de Reumatologia. Published by Elsevier Editora Ltda. 
All rights reserved.
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Construção do manual de processos de trabalho e técnicas do Centro de 
Dispensação de Medicamentos de Alto Custo (CEDMAC) do Hospital de 
Clínicas da Unicamp
Palavras-chave:
Reumatologia
Terapia biológica
Administração hospitalar
Garantia da qualidade dos cuidados 
de Saúde
r e s u m o
Os Centros de Medicação de Alto Custo (CEDMAC) da Secretaria de Saúde do Estado de São 
Paulo foram instituídos por projeto em parceria com Hospital das Clínicas da Faculdade de 
Medicina da USP, patrocinado pela Fundação de Amparo à Pesquisa do Estado de São Paulo 
(FAPESP), visando à formação de rede estadual para atendimento integral dos pacientes 
indicados ao uso de agentes imunobiológicos nas doenças reumatológicas. O CEDMAC do 
Hospital de Clínicas da Universidade Estadual de Campinas (HC-Unicamp), implementado 
pela Disciplina de Reumatologia da Faculdade de Ciências Médicas, identificou a neces-
sidade de padronização das condutas da equipe multidisciplinar, frente à especificidade 
da assistência, verificando a importância da descrição, em formato de manual, dos seus 
processos de trabalho e técnicas. O objetivo do estudo foi apresentar a metodologia de 
construção do manual do CEDMAC/HC-Unicamp como ferramenta institucional, visando 
à qualidade assistencial e administrativa. A metodologia para elaboração dos manuais no 
HC-Unicamp, desde 2008, tem como premissas ser participativo, multidisciplinar, focado 
em processos de trabalho, integrado às normas institucionais, com descrição objetiva e 
didática, formato padronizado e divulgação eletrônica. O Manual do CEDMAC/HC-Unicamp 
foi construído em dez meses, com o envolvimento de toda equipe multidisciplinar, tendo 
19 capítulos sobre processos de trabalho e técnicas, além dos relativos à estrutura orga-
nizacional e anexos. Publicado no portal eletrônico dos Manuais HC, em julho de 2012, 
como e-book, com registro ISBN 978-85-63274-17-5. O Manual tem sido valioso instrumento 
na orientação dos profissionais da área nas atividades assistenciais, de ensino e pesquisa.
© 2014 Sociedade Brasileira de Reumatologia. Publicado por Elsevier Editora Ltda. 
Todos os direitos reservados.
Introduction
The treatment of rheumatic diseases has changed markedly 
in the last 10 to 15 years, with the emergence of new drugs, 
the so-called biological therapies.1 
Disease-modifying drugs (DMDs) are conventional thera-
pies that can control about 20% of symptoms in approximate-
ly 55%-60% of patients; only 10%-20% attain a response of 70% 
of development of arthritis.2-4 However, there is a niche of pa-
tients who, even in association with conventional DMARDs,5 
do not achieve a good response or are intolerant (e.g., nausea 
with methotrexate, diarrhoea with leflunomide, maculopathy 
to antimalarials), requiring another pharmacological agent to 
improve symptoms and return to their productive lives.
Biologic therapies are so named because they are organic 
molecules of high molecular weight and have biological ori-
gin, i.e., produced by living beings and containing carbon at-
oms in their molecular structure. In general, the organic mol-
ecules used as substrates are immunoglobulins or antibodies.
However, their greater efficacy with greater specificity jus-
tifies the high cost, since the patient will be again a produc-
tive member of society. This will be possible after research on 
the physiopathogenesis, with biomolecular foundation, and 
on the activity in specific and critical points for a particular 
disease.6-10
In general, patients are lay people in the medical field, or 
even have a low level of education; thus, most of them are not 
equipped to handle (storage, application and disposal) self-
administered subcutaneous drugs or would not have a proper 
place for infusion of intravenous medications, and also do 
not have proper supervision. Being organic molecules, these 
drugs are very exquisite, requiring special care in their han-
dling or transport.
This can be observed in medical consultations, considering 
that it is the responsibility of the rheumatologist to evaluate 
the patient response to the prescribed medication. It is known 
that a closer monitoring of patients with rheumatologic dis-
ease results in a better response to treatment, compared with 
patients in routine visits every 3 to 6 months, as that strategy 
enables an earlier intervention.3-5,11 
Initially, this conduct of a more rigorous and closer follow-
up may seem more difficult and costly. However, in the study 
TICORA, a survey on costs was also done, showing no increase 
in financial costs and a better quality of care and improved 
response.5 
This strategy is practiced at CEDMAC, Health Department, 
São Paulo, considering that the visits take place with a shorter 
time interval and with the possibility of extra visits to check 
for effects and adverse events.
CEDMAC was established from a project developed in part-
nership between Hospital das Clínicas, Faculty of Medicine, 
USP, and Health Department of the State of São Paulo, and 
is sponsored by the Foundation for Research Support of the 
State of São Paulo (Fundação de Amparo à Pesquisa do Estado 
de São Paulo, FAPESP), aimed at the formation of a statewide 
network for dispensing costly medication. CEDMAC serves pa-
tients with an indication for use of immunobiological agents 
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in rheumatological diseases, and accompanies the indication, 
dispensing and application of these medications. Another 
important function of the Centers is the registration of users 
for reporting side effects; thus, CEDMAC can feed data into 
Brazilian Registry of Biological Rheumatology (BiobadaBrasil). 
The role of specialist nurses is also crucial, because in 
addition to being familiar with terms and conditions, these 
professionals are also aware of the conventional drugs and, 
in the case of CEDMAC, of this new class of antirheumatic 
drugs. Thus, the specialist nurses interfere in the patients’ 
education – on what is the disease, treatment options, the 
proper use of medication, and improvement in the degree of 
fidelity to its use. Thus, these professionals help increase the 
response to therapy. In some countries, these professionals 
even count joints and advice on contraception.
Another important role of CEDMAC is to establish inno-
vative conduct protocols on biologicals, following the most 
current recommendations. By being in the public university 
scenario, the scientific knowledge is considered an essential 
factor, together with the reduction of costs. One of the main 
terms that enter into discussion in the context of biological 
drugs, particularly in the use of infusion drugs, is how to re-
duce the infusion time for each patient, increasing vacancies 
and obtaining full efficiency of the service with the highest 
quality possible.9,10
Since this is a statewide network of centers for dispensing 
and infusion of high-cost drugs (especially biologicals) in the 
field of rheumatology, there is the possibility of exchanging 
information with other centers, with the aim of standardizing 
the care in the State of São Paulo, with sharing of experiences.
The CEDMAC/HC-Unicamp was implemented by the De-
partment of Rheumatology, Faculty of Medical Sciences. Its 
main goal is to benefit rheumatological patients with the use 
of biological drugs, with respect to guidance on this type of 
medication, its proper use and supervision as to their doubts 
and responses to therapy. Thereby, the CEDMAC also inter-
feres to avoid the improper use or misuse of medications, as 
well as their loss. 
Moreover, CEDMAC also must train specialized teams that 
will deal with this type of patient and drug, offering appropri-
ate multidisciplinary care and providing more welfare to the 
rheumatic patient. In addition, data are generated from stan-
dardized consultations, with production of clinical research 
and exchange of information and experiences with other 
CEDMACs of São Paulo. 
Considering the specificity of the assistance offered and 
the need for a clear standardization of conducts for the mul-
tidisciplinary team, it became important to develop and de-
scribe, in manual format, the work processes and techniques 
of CEDMAC/HC-Unicamp.
In the literature and in all certification programs adopted 
by healthcare institutions, there is consensus on the need of 
elaboration of operational manuals, even if the nomenclature 
of these documents may vary according to the source con-
sulted: manuals of routines, norms, procedures, techniques, 
processes, or of standardized operating procedures.12,13
The manual is an administrative instrument that allow the 
organization and standardization of service guidelines in a 
health care institution, systematizing activities and their ex-
ecution by different professionals; moreover, this document 
establish points of process control and of measurement of 
results.14 Manuals give subsidies for training and supervision 
of procedures, reducing the risk of adverse events, facilitating 
the revision of processes, meeting the requirements of regula-
tory agencies and offering protection against lawsuits gener-
ated by patients or labourers.
It is known that people produce better when following a 
standardized routine. This standardization reduces the vari-
ability of offered products or services, and this translates 
into predictable and reliable processes. The manual should 
serve as a reference document, being used for training 
teams to operate the work process. Moreover, the manual 
can function as a tool which facilitates the dissemination 
of institutional knowledge, as a benefit within reach of all 
interested.12,15
A discussion that still occurs in the healthcare scenario 
relates to the supposed difficulty in developing manuals for 
this sector, in which every patient is an unique being, with 
an absolutely peculiar clinical picture. In reality, what are in-
tended to standardize are the processes likely to be used, and 
not the assistance to be provided.16
A good standardization must demonstrate essential char-
acteristics: it must arise from those professionals who per-
form the tasks, be the result of consensus, be simple and 
based on institutional practice, should address more frequent 
and higher risk/complexity situations, be consistent with the 
recommendations and literature, follow a standard format 
and be accessible to all members of the institution. No sin-
gle model exists for a manual elaboration. These documents 
may vary as to content, level of detail and format, according 
to the needs of each institution. Manuals are flexible, never 
complete or finished works, and depend on constant review 
and updating.17
Objective
To present the methodology of elaboration of the manual of 
work processes and techniques for CEDMAC/HC-Unicamp as 
an institutional tool, aiming to the best care and administra-
tive quality.
Material and methods
The HC-Unicamp develops, since 2008, a program of institu-
tional elaboration of manuals, entailed to and supported by, 
Hospital Superintendence, with clearly defined premises and 
logistical support for elaborating and formatting manuals, fa-
voring the adhesion of multidisciplinary teams and the proj-
ect success.18 
The premises of HC-Unicamp Manuals are:
rParticipative elaboration – to involve professionals from 
different hierarchical levels in the processes’ description 
in the area. 
rDescription by processes, where possible, with multipro-
fessional, interareas and multidisciplinary approaches – to 
involve all professional categories in the preparation of the 
manual, and to describe the processes, allowing the dem-
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onstration of the interrelationship of the multidisciplinary 
team and the different areas of the institution. 
rAddress liability processes of the area – to describe only 
proper and specific processes of the area.
rTo reflect the reality and current practice – the manual 
must not describe idealized processes, but those that, in 
fact, are practiced; thus, in practice the motto prevails: 
Write what you do and do what is written!. 
rDepth and detail are determined by demand and interest 
in the area – due to its specificity, each area determines 
what are the important processes to be described and 
what level of detail is necessary to their reality.
rObjective, didactic and attractive description, with a focus 
on target audience – to avoid excessively detailed descrip-
tions that make the reading process a tiresome thing. Use 
simple and direct language, favouring clarity.
rA standardized format – operational help for manual for-
matting and configuration of an institutional document, 
in accordance with the recommendations of certification 
programs and literature: standardized header and footer 
containing institutional logos, authors, implantation date, 
revision date, revision number, author and signature of the 
professional in charge of the area in question; use of docu-
ments and descriptive papers of activities already existing 
in the area, with its conversion to standard format. 
rCompatibility and integration with manuals from other ar-
eas – to avoid repetitions and contradictions among manu-
als of different areas. 
rPriority in dissemination and electronic use – to create, 
in the community, the habit of searching for information 
in the manuals in electronic format, avoiding the use of 
printed copies.18
The content of the manual covers: 
rMission and/or objectives of the area;
rArea relationship map – consists in a model that represents 
the relationship between supplier, input, process, output and 
customers;
rMacroflow of operational process of the area;
rDescription of the various processes of the areas, highlighted 
in the analytical index;
rDescription of the standards of occupational safety in each 
specific operational process;
rAnnexes relevant to each area, such as: regulatory standards, 
bibliographies, used documents and guidance booklets.
After all processes were described in a certain area, the 
manual is referred to the Committee on Hospital Infection 
Control, that will analyze all procedures and techniques with 
which this document interfaces, assessing its compliance to 
standards and guidelines established for the infection control 
in the institution. If there is any non-compliance, a meeting 
is scheduled with the participation of members of the area of 
the manual in question and the HC-Manuals project coordi-
nator, besides professionals of CCIH, for the needed conducts’ 
agreement. After the arrangements, the president of CCIH 
signs the processes with which he/she has interface.18
In parallel, the manual is also forwarded to the Labor 
Safety Service that performs the analysis of the activities and 
prepares technical recommendations for occupational safety. 
Regarding the use of individual protection, collective protec-
tion and protection barriers’ equipment, as prescribed by leg-
islation, in particular the Regulatory Standards of the Ministry 
of Labor and Employment and those issued by the National 
Health Surveillance Agency (Agência Nacional de Vigilância 
Sanitária, ANVISA) and the Brazilian Association of Technical 
Standards (Associação Brasileira de Normas Técnicas, ABNT). 
After the analyses, utterance of technical recommendations, 
and alignment of occupational safety conducts, the manual is 
signed by the labor safety technician in charge.18
With the final approval and signature of the professional in 
charge of the area in question, the document is converted to 
pdf, using a security system that prevents changing contents, 
printing and text fragments copying. This measure aims to pre-
vent misuse of the document, especially unnecessary copies 
and plagiarism. Moreover, in order to improve the institutional 
control of all manuals issued, these are registered in the Inter-
national Standard Book Number (ISBN) in e-Book format.18
Subsequently, the manual is forwarded to the Division of 
Informatics for allocation to a specific directory on the hos-
pital’s central server. In this directory, all books available for 
consultation can be found at a portal accessed by care net-
work and intranet (Fig. 1). The access is free throughout HC-
UNICAMP in more than 1.700 computers. Currently, there are 
79 manuals of support, care areas, and management avail-
able for consultation. 
Although each area has a printed copy of its manual, the 
electronic access is highly encouraged because of its advan-
Fig. 1 – Images from the manual’s Portal, HC-Unicamp.
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tages: less paperwork, continuous and simultaneous access to 
manuals, frequent updating of content, access to all manuals 
and not only to that of a specific area, quick identification of 
the desired process and easy consultation.
Results
The manual of work processes for CEDMAC-HC-Unicamp was 
elaborated in a period of 10 months, in a participative man-
ner with involvement of the entire multidisciplinary team, and 
published in the electronic portal of HC-Manuals in July 2012 in 
form of e-Book (ISBN 978-85-63274-17-5). 
The organizational structure of CEDMAC was addressed 
through:
rDescription of the objectives of the area in question, en-
compassing the intervention in care, teaching and research.
rMap of supplier/process/client relationship that presents 
the interrelationships of the area with its key suppliers and 
internal and external customers (Fig. 2).
rMacroflow of the operational process that summarizes, in 
graphic presentation, the care process (Fig. 2).
In order to provide a basic technical knowledge indispens-
able to a good care practice by non-specialist professionals 
of major and secondary levels, a chapter has been prepared 
addressing the biological drugs used in CEDMAC (Fig. 3) with 
respect to: 
r %JGGFSFODFT CFUXFFO USBEJUJPOBM BOE CJPMPHJDBM NFEJ-
cines.
r$MBTTFTPGCJPMPHJDBMTVTFEJOSIFVNBUPMPHZ
r.BKPSCJPMPHJDBMESVHTVTFEUIFJSDIBSBDUFSJTUJDTJOEJDB-
tions, contraindications and usual dosage. 
The structure and operating rules of CEDMAC were de-
scribed, as well as the duties of the professionals involved, 
specifying their accountability for tasks and hierarchical 
bonds. The profile of patients and their flow of access to the 
service were detailed. The origin of the administered medica-
tions, acquisition routine, control and care for their preserva-
tion were also described.
Chapters on the technique of preparation and adminis-
tration for each biological medicine used in CEDMAC were 
elaborated: infliximab, adalimumab, etanercept, abatacept, 
rituximab, tocilizumab (Fig. 3). Chapters were also prepared 
for zoledronic acid and cyclophosphamide that, although not 
biologicals, are eventually prescribed and require special care 
in their preparation and administration. The most frequent 
adverse events in the administration of these drugs and the 
recommended actions were also highlighted.
Specific chapters detailed medical procedures and the sys-
tematization of nursing care performed in CEDMAC, as well 
as for administrative, teaching and research activities. 
A total of 19 chapters describing the work process and 
techniques were elaborated, besides those relating to the or-
ganizational structure and annexes (references, documents 
used in the area, a chronological table of educational docu-
ments and folders).
Discussion
Despite the hard work represented by the elaboration of the 
manual and of the required dedication of the multidisciplinary 
team, the results clearly justify it. Throughout the preparation 
process, care practices can be revised according to the literature 
and manufacturers’ guidelines for their own drugs, in relation 
to precautions in storage, preparation, application and user as-
sistance. Small variations in practice between practitioners of 
CEDMAC regarding the handling of products were observed; 
this way, there is opportunity for adjustments of conduct.
The possession of work processes and of described and ac-
credited techniques facilitates the dissemination of specific 
technical knowledge of the area, the integration of new profes-
sionals, a continuing education for the multidisciplinary team 
and supervision of procedures.
Due to its teaching and research activities (characteristics of 
HC-UNICAMP), the manual can also function as a guidance tool 
for trainees, including medical residents and graduate students.
In addition to these benefits, with the manual of work pro-
cesses and techniques from CEDMAC HC-Unicamp, there is 
a possibility of exchanging of information and experiences 
with other centers of infusion of biologic medicines in the 
area of rheumatology.
Fig. 2 – Map of relationship and macro flow of the 
operational process of CEDMAC HC-Unicamp.
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